LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma
Huamei Wei,Xianjian Wu,Lizheng Huang,Chen Long,Qi Lu,Zheng Huang,Yanyan Huang,Wenchuan Li,Jian Pu
DOI: https://doi.org/10.2147/jhc.s449090
2024-03-11
Journal of Hepatocellular Carcinoma
Abstract:Huamei Wei, 1, &ast Xianjian Wu, 2, &ast Lizheng Huang, 3, &ast Chen Long, 3 Qi Lu, 3 Zheng Huang, 3 Yanyan Huang, 3 Wenchuan Li, 2 Jian Pu 2 1 Department of Pathology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, People's Republic of China; 2 Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, People's Republic of China; 3 Graduate College of Youjiang Medical University for Nationalities, Baise, Guangxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jian Pu, Affiliated Hospital of Youjiang Medical University for Nationalities, No. 18 Zhongshan Two Road, Baise, Guangxi, 533000, People's Republic of China, Email Objective: Tumor-associated macrophages play a crucial role in the development of hepatocellular carcinoma (HCC). Our study aimed to investigate the relationship between long coding RNA (lncRNA) maternally expressed gene 3 (MEG3), RNA-binding protein human antigen R (HuR), and messenger RNA C–C motif chemokine 5 (CCL5) in the modulation of M1 and M2 macrophage polarization in HCC. Methods: To induce M1 or M2 polarization, LPS/IFNγ- or IL4/IL13 were used to treat bone marrow derived macrophages (BMDMs). The localization of MEG3 in M1 and M2 macrophages was assessed using fluorescence in situ hybridization assay. Expression levels of MEG3, HuR, CCL5, M1, and M2 markers were measured by RT-qPCR or immunofluorescence staining. Flow cytometry was performed to determine the proportion of F4/80+CD206+ and F4/80+CD68+ cells. RNA pulldown assay was performed to detect the binding of lncRNA MEG3 and HuR. The impacts of HuR on CCL5 stability and activity of CCL5 promoter were evaluated using actinomycin D treatment and luciferase reporter assay. Cell migration, invasiveness, and angiogenesis were assessed using transwell migration and invasion assays and a tube formation assay. A mixture of Huh-7 cells and macrophages were injected into nude mice to explore the effect of MEG3 on tumorigenesis. Results: MEG3 promoted M1-like polarization while dampening M2-like polarization of BMDMs. MEG3 bound to HuR in M1 and M2 macrophages. HuR downregulated CCL5 by inhibiting CCL5 transcription in macrophages. In addition, overexpression of MEG3 suppressed cell metastasis, invasion, and angiogenesis by obstructing macrophage M2 polarization. MEG3 inhibited tumorigenesis in HCC via promotion of M1-like polarization and inhibition of M2-like polarization. Rescue experiments showed that depletion of CCL5 in M2 macrophages reversed MEG3-induced suppressive effect on cell migration, invasion, and tube formation. Conclusion: MEG3 suppresses HCC progression by promoting M1-like while inhibiting M2-like macrophage polarization via binding to HuR and thus upregulating CCL5. Keywords: hepatocellular carcinoma, maternally expressed gene 3, macrophage polarization, human antigen R, C-C motif chemokine 5 Hepatocellular carcinoma (HCC) ranks sixth among the most common malignant tumors worldwide. 1 Metastasis and recurrence are two main factors obstructing HCC treatment. 2 Tumor microenvironment (TME) contributes to tumor tissue formation, metastasis, and survival by harboring tumor cells. 3–5 Despite cancer cells, TEM is also formed by immune cells, endothelial cells, stromal cells, and cancer-associated fibroblasts. 6 Tumor-associated macrophages (TAMs) are main components of the TME and are associated with the survival of patients diagnosed with HCC. 7 Monocytes produced in the bone marrow or spleen infiltrate tumors and differentiate into TAMs. 8 Under different stimulations, monocytes differentiate into macrophages with antitumor property (M1-like) or tumor promoting capacity (M2-like). Macrophages with an M2-like phenotype promote tumor growth by reducing cytotoxic cell populations such as natural killer cells and CD8+ T cells. 8 At present, main interventions for TAM-based antitumor therapy include inhibiting macrophage recruitment, enhancing M1 antitumor activity, suppressing M2 tumor-promoting activity, and inducing TAM apoptosis and death. 8 Previous studies have revealed that HCC in C4 subtype is characterized by enrichment of M2 macrophages and inhibition of the Th1 CD4 + T cell response. 9,10 D-lactate remodels immunosuppressive TME in HCC by transforming M2 TAMs to M1. 11 Therefore, targeting the function and polarization of TAM can be developed as effective therapeutic strategies against HCC. Long non -Abstract Truncated-
oncology